Metastasis Research Network (U54 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Cancer Institute, part of NIH, is seeking applications for the Metastasis Research Network to support U54 Specialized Centers that advance a comprehensive understanding of cancer metastasis. Each center must propose an overarching scientific theme and carry out two or three interdisciplinary basic research projects as the hub of MetNet, with an Administrative Core and at least two Research Projects, and an optional Shared Resource Core. The work must use integrative, systems-level approaches to address at least two major elements of metastasis, and proposals focused on a single element, population-level epidemiology, or clinical trials will not be reviewed; foreign organizations may apply, but foreign subawards or subcontracts are not allowed. NCI plans to fund four awards with a total of $6.8 million in FY 2027, with budgets capped at $1.3 million per year for up to five years. Applications are due September 25, 2026, and the listed contact is NCIMetNet@mail.nih.gov.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.